Anthony Fernandez
Dermatology · Cleveland, OHNPI 1720298318
Payments from drug & device makers
Across 382 payments — averaging $3689.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$488K
- Mallinckrodt Hospital Products Inc.$322K
- AstraZeneca$116K
- AbbVie$93K
- Incyte Corporation$63K
- E.r. Squibb & Sons, L.L.C.$61K
- plus $266K from 21 others
Across 3 payments — averaging $2190.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
- EMD Serono, Inc.$2K
- AbbVie$2K
What the payments were for
- Consulting fees$74,00721%
- Speaking & faculty fees$258,72973%
- Travel & lodging$11,1923%
- Food & beverage$8,2662%
- Education$1130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 75 | $488,169 |
| Mallinckrodt Hospital Products Inc. | 33 | $321,933 |
| AstraZeneca(2 entities) | 6 | $116,166 |
| AbbVie | 81 | $92,627 |
| Incyte Corporation | 1 | $63,013 |
| E.r. Squibb & Sons, L.L.C. | 48 | $61,303 |
| Astrazeneca UK Limited | 1 | $39,300 |
| Hoffmann-la Roche Limited | 4 | $36,316 |
| Boehringer Ingelheim | 3 | $34,856 |
| Galderma Laboratories, L.p. | 26 | $34,186 |
| Novartis | 28 | $33,703 |
| Mallinckrodt Enterprises LLC | 16 | $19,031 |
| Therakos LLC | 7 | $18,768 |
| Kyowa Kirin, Inc. | 13 | $11,343 |
| UCB, Inc. | 8 | $10,664 |
| Boehringer Ingelheim International GmbH | 12 | $8,242 |
| Amgen | 5 | $5,317 |
| Sanofi | 4 | $4,425 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,990 |
| Johnson & Johnson | 1 | $3,600 |
| Biogen | 2 | $1,982 |
| Boston Scientific | 1 | $148 |
| Dermavant Sciences, Inc. | 2 | $121 |
| Argenx US, Inc. | 1 | $69 |
| Octapharma USA, Inc. | 1 | $51 |
| Janssen Scientific Affairs, LLC | 1 | $44 |
| Sun Pharmaceutical Industries Inc. | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,409,403 in reported general payments places this provider in the 95th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 100 | $1,556,451 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 19 | $415,843 |
| Taltz AutoinjectorIxekizumab | 28 | $233,825 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 39 | $180,625 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 14 | $172,647 |
| Mycophenolate Mofetil | 37 | $5,285 |
| Dapsone | 17 | $2,802 |
| Hydroxychloroquine Sulfate | 38 | $1,652 |
| Tacrolimus | 11 | $932 |
| MethotrexateMethotrexate Sodium | 59 | $901 |
| Doxepin Hcl | 13 | $810 |
| Sodium Chloride0.9 % Sodium Chloride | 45 | $530 |
| Solu-MedrolMethylprednisolone Sod Succ/Pf | 13 | $529 |
| Triamcinolone Acetonide | 39 | $470 |
| Dexamethasone | 16 | $393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $3,990 | $1,556,451100 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 460 dermatology providers in Ohio.
Other dermatology in Cleveland
- Neil KormanCleveland$6M
- Wilma BergfeldCleveland$642K
- Shilpi KhetarpalCleveland$383K
- Edward MaytinCleveland$190K
- Alex HirshCleveland$159K
- Mara Weinstein VelezCleveland$129K
- Samantha PollyCleveland$80K
- Matthew ZirwasBexley$7.4M
- Jeffrey TraversDayton$4.7M
- Jennifer NashWesterville$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.